Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3266522 | Digestive and Liver Disease | 2007 | 9 Pages |
Abstract
Antisense gene therapy targeting αV integrins warrants consideration as an approach to treat hepatocellular carcinomas.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
J. Li, H. Tan, X. Dong, Z. Xu, C. Shi, X. Han, H. Jiang, G.W. Krissansen, X. Sun,